News

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...
Morningstar10d
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
Global ICON survey shows need for more efficient ... approaches in their obesity-related research. However, the survey results also suggest that sponsors may underestimate the complexity of ...